Simplify Exchange Traded Funds Simplify Propel Opportunities ETF (ARCA: SURI)
Ticker | Name | Share % | |
---|---|---|---|
PAGP | Plains Gp Holdings, L.p., Class A | 24.91% | |
APLT | Applied Therapeutics, Inc. Com | 15.24% | |
TCRX | Tscan Therapeutics Inc | 6.83% | |
MDGL | Madrigal Pharmaceuticals Inc | 6.20% | |
AKRO | Akero Therapeutics Inc | 5.75% | |
PHAT | Phathom Pharmaceuticals Inc | 5.70% | |
RNA | Avidity Biosciences Inc | 5.32% | |
ATHA | Athira Pharma, Inc Prvhld | 4.64% | |
FULC | Fulcrum Therapeutics Inc(180 Day Lockup) | 4.00% | |
ARDX | Ardelyx Inc | 3.62% |
The SURI ETF is currently trading at $16.10, which represents a -2.07% change. Over the past 52 weeks, the ETF has traded as high as $27.52 and as low as $14.82.
The expense ratio of SURI is 2.51%. This represents the annual fee that all funds or ETFs charge their shareholders.
The total Assets Under Management (AUM) for SURI is 100.76M. This represents the total market value of the assets managed by the ETF.
SURI follows a Allocation/Balanced investment style.
The top holdings of SURI include: PAGP (24.91%), APLT (15.24%), TCRX (6.83%), MDGL (6.2%), AKRO (5.75%). These represent the largest positions in the ETF's portfolio.
Average daily volume data for SURI is currently not available.